Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults [Phase 1, Phase 2]
Phase 1/2 clinical trial update on GR2001 evaluating safety, tolerability, PK/PD and immunogenicity in healthy Chinese adults for tetanus.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a tetanus and diphtheria vaccine.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) [Phase 4]
Phase 4 study assessing safety, tolerability, and immunogenicity of the hexavalent vaccine Vaxelis in children previously vaccinated with Va…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Phase 3]
Phase 3 trial update for a diphtheria-tetanus-acellular pertussis-inactivated poliovirus combination vaccine were completed.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the immunogenicity and safety of LBVD(Hexavalent Vaccine) in healthy infants as part of the primary seri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants [Phase 2]
A Phase 2 clinical trial evaluating the safety and immunogenicity of the Boostrix vaccine in pregnant Malian women and their infants, with r…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Tdap Vaccine Safety for Plasma Donors [Phase 2, Phase 3]
Phase 2/3 trial update evaluating safety of Tdap vaccine for plasma donors; results posted with completion in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants [Phase 3]
Phase 3 trial comparing primary and booster DTaP-IPV-Hib vaccinations to co-administration of DTaP-IPV and Hib in Japanese infants; study co…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of Sanofi Pasteur's combined vaccine given as a three-dose primary series in i…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants [Phase 3]
Phase 3 clinical trial evaluating DTaP-IPV-HB-PRP-T as a primary series and a second-year booster in HIV-exposed infants (infected and uninf…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children [Phase 3]
Phase 3 trial assessing immunogenicity and safety of BR-TD-1001 given intramuscularly in healthy children completed.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of DTaP-IPV vaccine as a booster in healthy children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: Intrathecal Tetanus Immunoglobulin to Treat Tetanus [Phase 1, Phase 2]
A clinical trial update on intrathecal tetanus immunoglobulin for treating tetanus, spanning Phase 1 and Phase 2, with completed status.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in healthy sub…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines [Phase 3]
Phase 3 trial comparing three lots of GSK DTaP-IPV candidate vaccine to DTaP + IPV vaccines; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of GC3111 in healthy adults for tetanus, diphtheria, and pertussis. Status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boo…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). [Phase 3]
Phase 3 immunogenicity and safety trial evaluating combined or separate vaccines against common childhood diseases in infants (2, 4, 6 month…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects [Phase 3]
Phase 3 trial evaluating immunogenicity, safety, and reactogenicity of Boostrix booster in healthy Russian adults completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants [Phase 2]
Phase 2 study assessing safety and immunogenicity of a hexavalent DTwP-HepB-IPV-Hib vaccine in healthy infants; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: A Phase IV Study to Assess the Safety of EupentaTM Inj [Phase 4]
Phase IV study update assessing the safety of EupentaTM Inj; the document lists multiple conditions and an unknown status for the trial.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia [Phase 3]
Phase 3 trial assessing immunogenicity and safety of Infanrix-IPV/Hib given in a three-dose schedule with a booster in healthy infants in Ru…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 immunogenicity and safety study of Infanrix Hexa in healthy infants, including those born to mothers vaccinated during pregnancy or …
-
CLINICAL_TRIALS safety_alert · 2019-03-29Clinical Trial Update: Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea
Post-marketing surveillance study assessing the safety of the Boostrix vaccine according to prescribing information in Korea has completed; …